Latest Veridex LLC Stories

2009-07-13 07:45:00

RARITAN, N.J., July 13 /PRNewswire/ -- Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10 issue of the Journal of Clinical Oncology.

2009-05-07 08:00:00

Proprietary Veridex Technology is the First Cancer Diagnostic Test to Automate and Capture Circulating Tumor Cells RARITAN, N.J., May 7 /PRNewswire/ -- Veridex, LLC announced today that the CellSearch(R) System to measure circulating tumor cells (CTCs) will be offered at Florida Cancer Specialists (FCS), the largest privately-owned oncology and hematology practice in Florida.

2008-11-12 12:00:07

RARITAN, N.J., Nov. 12 /PRNewswire/ -- Veridex, LLC announced today that the technology used in the CellSearch(R) System to measure circulating tumor cells (CTCs) was ranked as the top medical innovation for 2009 by the Cleveland Clinic, a leading multispecialty academic medical center.

2008-08-01 18:00:36

Immunicon Corporation (OTCBB:IMMC.OB) announced today that Immunicon Corporation and its wholly-owned subsidiaries completed their previously announced sale of substantially all of their assets to Veridex, LLC ("Veridex") in a sale conducted under the provisions of Section 363 of the U.S.

2008-08-01 18:00:36

RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today it has completed its previously announced acquisition of substantially all of the assets of Immunicon Corporation (BULLETIN BOARD: IMMC) and its wholly-owned subsidiaries.

2008-07-24 18:00:23

RARITAN, N.J., July 25 /PRNewswire/ -- An international, prospective clinical trial found the number of circulating tumor cells (CTCs) is a strong indicator of progression-free and overall survival among metastatic colorectal cancer patients, according to a report published in the July 1 issue of the Journal of Clinical Oncology.

2008-07-18 00:00:15

Research and Markets Laura Wood, Senior Manager Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 press@researchandmarkets.com Logo: http://www.researchandmarkets.com Research and Markets (http://www.researchandmarkets.com/research/ 8d3dd7/commercializing_mo) has announced the addition of the "Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market" report to their offering.

Word of the Day
  • The horn of a unicorn considered as a medical or pharmacological ingredient.
  • A winged horse with a single horn on its head; a winged unicorn.
The word 'alicorn' comes from Italian alicorno, already associated with unicorns and reinterpreted, popularized by Bearing an Hourglass (1984) and other fantasy novels by Piers Anthony.